Mohamad Mohty
Professor of Hematology and past-president of the European society for Blood and Marrrow Transplantation (EBMT)
Last synced from Twitter 16m ago
The Lifesaving Power in Stem Cells
Liars and thieves should not be allowed to detract from legitimate scientific research that has made umbilical cord blood mystic in its regenerative powers.
Is allo-SCT still relevant in the immuno-oncology era for Hodgkin lymphoma?
Miguel-Angel Perales, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses the current status of allogenic hematopoietic stem cell transplantation in Hodgkin lymphoma. Speaking at the European Society for Blood and Marrow...
The Recurring Problem of Drug Shortages—How Do We Overcome It? | Atlantis Press
Mohamad Mohty
The Recurring Problem of Drug Shortages—How Do We Overcome It? | published in Clinical Hematology International by @TheIACH
35h
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant
Acute myeloid leukemia (AML) with FLT3-mutation carries a poor prognosis, and allogeneic stem cell transplantation (allo-SCT) is recommended at first complete remission (CR1). We assessed 462 adults (median age 50 years) with FLT3-mutated AML...
Mohamad Mohty
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival.
published in Clinical Hematology International by @TheIACH
35h
Challenges in Conducting Studies in Chronic Graft-versus-Host Disease | Atlantis Press
The lack of standardized criteria for measuring therapeutic response has been a major obstacle to the development of therapeutic trials in chronic graft-versus-host disease (cGvHD). Nevertheless, recent advances have been made in understanding of...
Mohamad Mohty
Challenges in Conducting Studies in Chronic Graft-versus-Host Disease | published in Clinical Hematology International by @TheIACH
35h
Current Status and Perspectives of Irradiation-Based Conditioning Regimens for Patients with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation | Atlantis Press
Acute myeloid leukemia and acute lymphoblastic leukemia are the most common indications for allogeneic hematopoietic stem cell transplantation. Total body irradiation (TBI) is an important part of conditioning regimens. TBI-based regimens offer...
Mohamad Mohty
Current Status and Perspectives of Irradiation-Based Conditioning Regimens for Patients with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation | published in Clinical Hematology International by @TheIACH
35h
Management of AML Beyond “3 + 7” in 2019 | Atlantis Press
The therapeutic paradigm for treatment of acute myeloid leukemia (AML) is rapidly changing with the advent of a new generation of drugs targeting diverse aspects of leukemogenesis. Whereas standard treatment for AML until recently consisted of a...
Mohamad Mohty
Management of AML Beyond “3 + 7” in 2019 | published in Clinical Hematology International by @TheIACH
35h
Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease | Atlantis Press
The growing understanding of the bidirectional relationship between the gastrointestinal (GI) microbiome and the immune system has opened up new avenues for treatment of graft-versus-host disease (GVHD). Fecal microbiota transplantation (FMT) is the...
Mohamad Mohty
Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease published in Clinical Hematology International by @TheIACH
35h
Idiopathic Aplastic Anemia: An Update | Atlantis Press
“Bone marrow failure” encompass all the conditions and syndromes in which there are qualitative or quantitative disorders of one or more lineages (erythroid, myelomonocytic, and/or megakaryocytic). A few years ago, the pathophysiology of these...
Mohamad Mohty
Idiopathic Aplastic Anemia: An Update published in Clinical Hematology International by @TheIACH
35h
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma
Multiple myeloma (MM) is one of the most common hematological malignancies. Developing an effective treatment strategy for refractory/relapsed (R/R) MM represents a major challenge. In this trial, 17 R/R MM patients, who had previously experienced...
1
Mohamad Mohty
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma | PNAS
3d
Real-world data: towards achieving the achievable in cancer care
In the past few years, the use of data from the real world has garnered increasing interest; however, studies using real-world data (RWD) should not be used as substitutes for clinical trials. The authors of this Review explore the quality of RWD,...
Association of Patient Characteristics and Tumor Genomics With Non–Small Cell Lung Cancer Outcomes
This cancer epidemiology study links electronic health record (EHR) data with comprehensive genomic profiling to identify patient characteristics and gene alterations associated with overall survival, response to targeted and immune therapies, and...
Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement
Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement
Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study. - PubMed - NCBI
BMC Cancer. 2019 Mar 25;19(1):264. doi: 10.1186/s12885-019-5467-x.
Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies | Atlantis Press
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy derived from precursors of plasmacytoid dendritic cells. There is no established standard therapy for BPDCN and the efficacy of conventional...
Mohamad Mohty
Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies | By @TheIACH
4d
Mohamad Mohty
Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies | published in Clinical Hematology International by @TheIACH
35h
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Clinical Hematology International - volume 1, issue 1, 1 | Atlantis Press
Mohamad Mohty
The first issue of Clinical Hematology International, the open access journal of @TheIACH is available for download on : atlantis-press.com/journals/chi/i…
Please submit your best papers to Clin Hematol Int. No submission fees and no page charges.@mtmdphd @DrMiguelPerales @VincentRK
4d
Mohamad Mohty
The first issue of Clinical Hematology International, the open access journal of @TheIACH is available for download on : atlantis-press.com/journals/chi/i…
Please submit your best papers to Clin Hematol Int. No submission fees and no page charges.@mtmdphd @DrMiguelPerales @VincentRK
4d
Mohamad Mohty
Clinical Hematology International - volume 1, issue 1, 1 by @TheIACH - Open access
Hope you will enjoy reading this superb issue
4d
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease
Chronic graft-versus-host disease (cGVHD) continues to be a major complication after allogeneic hematopoietic cell transplantation, significantly affe…
The Day I Was Schooled on CME
The Day I Was Schooled on CME - Editor's Corner, Perspectives - ASH Clinical News